Ontology highlight
ABSTRACT:
PROVIDER: PRJNA1012299 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR25905804_1.fastq.gz | Fastqsanger.gz | |||
| SRR25905804_2.fastq.gz | Fastqsanger.gz | |||
| SRR25905805_1.fastq.gz | Fastqsanger.gz | |||
| SRR25905805_2.fastq.gz | Fastqsanger.gz | |||
| SRR25905806_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 86 |
Similar Datasets
Project description:Propidium monoazide-metagenomic analysis by 16S rRNA gene based sequencing with chilled food.
| PRJDB5378 | ENA
Project description:Evaluation of DNA array sensitivity to detect viruses in clinical samples following propidium monoazide treatment
| PRJNA266019 | ENA
Project description:Pan-viral DNA array (PVDA) and high-throughput sequencing (HTS) are useful tools to identify novel virus of emerging diseases. However, both techniques have difficulties to identify viruses in clinical samples because of host genomic DNA (hgDNA) contamination. Both propidium monoazide (PMA) and ethidium bromide monoazide (EMA) have the capacity to bind free DNA but are cell membrane-impermeable and thus are unable to bind protected DNA and RNA such as viral genomic material. DNA modified by EMA or PMA is not amplifiable by polymerase. In order to assess the capacity of EMA or PMA to lower hgDNA, serum or lung tissue homogenates were spiked with porcine reproductive and respiratory virus (PRRSV) and were processed with different combination of treatment: with or without ultracentrifugation and incubation with or without different concentration of EMA or PMA. PVDA and HTS were used to evaluate the capacity of both techniques to detect the presence of PRRSV from each sample. Negative results were obtained by PVDA and low amount of PRRSV specific reads were obtained by HTS with untreated samples or samples treated only by ultracentrifugation. An increase capacity of PRRSV detection was observable by PVDA in EMA and PMA treated samples but PVDA best results were obtained following PMA treatment, with or without ultracentrifugation. HTS sensitivity was also improved by a treatment with EMA or PMA, but the number of reads was significantly higher in PMA treated samples. These results support the use of PMA as a treatment to increase sensitivity of PVDA and HTS.
2015-11-02 | GSE62910 | GEO
Project description:Dissecting engineered cell types and enhancing cell fate conversion via CellNet
2015-08-04 | E-GEOD-59037 | ExpressionAtlas
Project description:Isopentenyl pyrophosphate (IPP) is the universal C5 precursor for isoprenoids, the largest class of natural products and frequent targets for metabolic engineering. In engineered microbial systems, IPP toxicity presents a challenge since its formation is unavoidable in the production of high-value, long-chain terpenes. In this work, we develop an experimental platform to study IPP toxicity in E. coli engineered to produce isoprenol, an IPP-derived C5 alcohol. We first characterize the physiological response to IPP accumulation, demonstrating that elevated levels of IPP are linked to growth inhibition, altered morphology, and reduced cell viability. We show that IPP toxicity selects for pathway “breakage”, using proteomics to identify a reduction in phosphomevalonate kinase (PMK) as a probable recovery mechanism. Next, we demonstrate that endogenous E. coli metabolism is globally impacted by IPP accumulation, which results in inhibited nutrient uptake, reduced ATP levels, and an apparent “pause” in metabolism. Finally, we suggest that IPP toxicity is mediated by the formation of an isoprenyl-ATP analog (ApppI). The complementary data presented here represent the most comprehensive assessment of IPP stress to date and suggest potential strategies for the alleviation of IPP and prenyl diphosphate toxicity.
2018-03-14 | GSE102672 | GEO
Project description:The impacts of man-made chemicals, in particular of persistent organic pollutants, are multifactorial as they may affect the integrity of ecosystems, alter biodiversity and hinder the health of most organisms. We have demonstrated that the belowground mycobiota of forest soils acts as a buffer against the pollution provoked by the biocide pentachlorophenol. However the trade-offs of the mitigation of the pollutant remain cryptic. To address this question we scrutinised the key changing aspects of a metacommunity of fungi when confronted (or not) with the biocide, comprising taxonomic and functional levels, as well as the identification of the major pollutant degraders within the metacommunity. Exposure to the biocide led to alterations in the metacommunity composition and functioning, many of which were not fully alleviated when most of the biocide was degraded, especially the dysregulation of the carbon and nitrogen metabolisms. The last is possibly linked to the higher pathogenic potential of the metacommunity after exposure to the biocide, supported by the secretion of proteins related to pathogenicity and reduced susceptibility to a standard fungicide. Our findings provide additional evidence for the silent risks of environmental pollution, particularly as it may favour the development of pathogenic trade-offs in fungi, which may impose serious threats to animals and plant hosts.
2018-11-28 | PXD009798 | Pride
Project description:Mesenchymal stem cell (MSC) therapy is a promising candidate for systemic lupus erythematosus (SLE), while more researches are needed to further improve therapeutic efficacy. In this study, engineered MSC aggregates are composited with MSC and cadherin/IGF1 functionalized PLGA composite microparticles, and are able to stimulate the microenvironment in vivo and enhance MSC functions of immunoregulation and cytokine secretion. Comprehensive characterization of these PLGA composite microparticles coated with E-cadherin/N-cadherin, enhancing MSC viability and cytokine secretion, followed by transcriptomic analysis to evaluate their potential advantages. We detected engineered MSC aggregates further ameliorated skin and lupus nephritis, compared with MSCs in MRL/lpr mice. In addition, engineered MSC aggregates enhanced Treg differentiation in vitro and in the spleen and lumph node of MRL/lpr mice. These findings suggested that engineered MSC aggregates represented a promising bioengineered approach for treating SLE, broadening the clinical applications of MSC-based therapies.
2024-10-01 | GSE276961 | GEO